DR. KEVIN LEE MOORE, M.D.
Osteopathic Medicine at 42 St, Oklahoma City, OK
License number
Oklahoma 16453
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
612 NW 42Nd St, Oklahoma City, OK 73118
Phone
(405) 397-7159
Professional information
Assistant Bank Examiner
Position:
Assistant Bank Examiner at Federal Reserve Bank of Kansas City
Location:
Oklahoma City, Oklahoma
Industry:
Banking
Work:
Federal Reserve Bank of Kansas City
- Oklahoma City, Oklahoma Area since Feb 2013
-
Assistant Bank Examiner
Morgan Stanley Wealth Management
- Oklahoma City May 2011 - Feb 2013
-
Financial Advisor
Northwestern Mutual
- Chicago, IL and Oklahoma City, OK Apr 2007 - May 2011
-
Financial Advisor
Sargent & Lundy
- Chicago, IL May 2005 - Mar 2007
-
Structural Engineer Associate I
United States Corp of Engineers
- Tulsa, Oklahoma Area May 2004 - Aug 2004
-
Engineer Intern
Federal Highway Administration
- Sterling, Virginia Jun 2003 - Aug 2003
-
Engineer Intern, STIPDG
Education:
University of Central Oklahoma 2012 - 2014
MBA, Business Oklahoma State University 2002 - 2005
Bachelor of Science (B.S.), Civil Engineering Northeastern State University 1999 - 2002
MBA, Business Oklahoma State University 2002 - 2005
Bachelor of Science (B.S.), Civil Engineering Northeastern State University 1999 - 2002
Skills:
Risk Management, Analysis, Budgets, Strategic Planning, Project Planning, Investments, Financial Analysis, Business Strategy, Finance, Strategic Financial Planning, Management, Morningstar, Banking, Financial Modeling, Financial Risk, Credit, Series 7
Interests:
History, business strategy, investing, volunteering and entrepreneurship.
Kevin Moore - Oklahoma City, OK
Work:
Federal Reserve Bank of Kansas City
Bank Examiner Morgan Stanley Smith Barney - Oklahoma City, OK
Financial Advisor Northwestern Mutual Financial Network - Chicago, IL
Financial Advisor Northwestern Mutual Financial Network - Chicago, IL
Trainer & Mentor Sargent & Lundy, LLC - Chicago, IL
Structural Associate
Bank Examiner Morgan Stanley Smith Barney - Oklahoma City, OK
Financial Advisor Northwestern Mutual Financial Network - Chicago, IL
Financial Advisor Northwestern Mutual Financial Network - Chicago, IL
Trainer & Mentor Sargent & Lundy, LLC - Chicago, IL
Structural Associate
Education:
University of Central Oklahoma
Master of Business Administration in General Business Oklahoma State University
Bachelor of Science in Civil Engineering
Master of Business Administration in General Business Oklahoma State University
Bachelor of Science in Civil Engineering
Skills:
Business Development, Leadership, Financial Analysis, Strategy
Kevin Lee Moore, Oklahoma City OK
Specialties:
Internal Medicine, Hematology
Work:
Oklahoma Medical Research
825 NE 13Th St, Oklahoma City, OK 73104
825 NE 13Th St, Oklahoma City, OK 73104
Education:
Indiana University(1982)
Tyrosylprotein Sulfotransferases
US Patent:
6713283, Mar 30, 2004
Filed:
Apr 11, 2003
Appl. No.:
10/411976
Inventors:
Kevin L. Moore - Oklahoma City OK
Assignee:
The Board of Regents of the University of Oklahoma
International Classification:
C12P 2106
US Classification:
435 691, 435193, 4352523, 4353201, 536 232
Abstract:
Tyrosylprotein sulfotransferases and nucleic acids encoding the tyrosylprotein sulfotransferases are described. Dual isotopes of the enzyme and of the nucleic acids encoding the enzymes have been identified in human, mouse and. The polypeptides and polynucleotides exhibit a wide range of homologies. The polynucleotides can be used to transform or transfect host cells for producing substantially pure forms of the enzyme, or for use in an expression system for post-translational tyrosine sulfation of proteins or peptides produced within the expression system. The enzymes can be used to sulfate peptides or proteins requiring sulfation.
Methods Of Treatment Using Antibodies To P-Selectin Glycoprotein Ligand
US Patent:
6667036, Dec 23, 2003
Filed:
Nov 18, 2002
Appl. No.:
10/299917
Inventors:
Richard D. Cummings - Edmond OK
Kevin L. Moore - Oklahoma City OK
Rodger P. McEver - Oklahoma City OK
Kevin L. Moore - Oklahoma City OK
Rodger P. McEver - Oklahoma City OK
Assignee:
The Board of Regents of the University of Oklahoma
International Classification:
A61K 39395
US Classification:
4241531, 4241301, 4241371, 4241411, 4241431, 4241521, 4241721, 4241731, 5303871, 5303875, 5303881, 5303882, 53038822, 5303891, 5303896, 5303887
Abstract:
P-selectin has been demonstrated to bind primarily to a single major glycoprotein ligand on neutrophils and HL-60 cells, when assessed by blotting assays and by affinity chromatography of [ H]glucosamine-labeled HL-60 cell extracts on immobilized P-selectin. This molecule was characterized and distinguished from other well-characterized neutrophil membrane proteins with similar apparent molecular mass. The purified ligand, or fragments thereof (including both the carbohydrate and protein components), or antibodies to the ligand, or fragments thereof, can be used as inhibitors of binding of P-selectin to cells, and to treat various conditions involving leukocyte binding via P-selectin glycoprotein ligand.
O-Glycan Inhibitors Of Selectin Mediated Inflammation Derived From Psgl-1
US Patent:
6124267, Sep 26, 2000
Filed:
Apr 20, 1998
Appl. No.:
9/063237
Inventors:
Rodger P. McEver - Oklahoma City OK
Richard D. Cummings - Edmond OK
Kevin L. Moore - Oklahoma City OK
Richard D. Cummings - Edmond OK
Kevin L. Moore - Oklahoma City OK
Assignee:
Southpac Trust Internationals, Inc.
International Classification:
A61K 3170
US Classification:
514 25
Abstract:
Tyrosine sulfate on PSGL-1, particularly at least one of residues 46, 48 and 51, functions in conjunction with sialylated and fucosylated glycans, most preferably Thr-57, to mediate high affinity binding to P-selectin. PSGL-1 O-glycans have been determined to consist of disialylated or neutral forms of the core-2 tetrasaccharide Gal. beta. 1. fwdarw. 4GlcNAc. beta. 1. fwdarw. 6(Gal. beta. 1. fwdarw. 3)GalNAcOH. A minority of the O-glycans are. alpha. 1,3 fucosylated that occur as two major species containing the sialyl Lewis x antigen--one species is a disialylated monofucosylated glycan:
Fuc. alpha. 1. dwnarw. 3 NeuAc. alpha. 2. fwdarw. 3Gal. beta. 1. fwdarw. 4GlcNAc. beta. 1. dwnarw. 6 NeuAc. alpha. 2. fwdarw. 3Gal. beta. 1. fwdarw.
Glycoprotein Ligand For P-Selectin And Methods Of Use Thereof
US Patent:
5464778, Nov 7, 1995
Filed:
Jul 21, 1994
Appl. No.:
8/278551
Inventors:
Richard D. Cummings - Edmond OK
Kevin L. Moore - Oklahoma City OK
Rodger P. McEver - Oklahoma City OK
Kevin L. Moore - Oklahoma City OK
Rodger P. McEver - Oklahoma City OK
Assignee:
Board of Regents of the University of Oklahoma - Norman OK
International Classification:
G01N 33564
US Classification:
436503
Abstract:
P-selectin has been demonstrated to bind primarily to a single major glycoprotein ligand on neutrophils and HL-60 cells, when assessed by blotting assays and by affinity chromatography of [. sup. 3 H]glucosamine-labeled HL-60 cell extracts on immobilized P-selectin. This molecule was characterized and distinguished from other well-characterized neutrophil membrane proteins with similar apparent molecular mass. The purified ligand, or fragments thereof (including both the carbohydrate and protein components), or antibodies to the ligand, or fragments thereof, can be used as inhibitors of binding of P-selectin to cells.
Tyrosylprotein Sulfotransferases And Methods Of Use Thereof
US Patent:
6204016, Mar 20, 2001
Filed:
Aug 13, 1999
Appl. No.:
9/374493
Inventors:
Kevin L. Moore - Oklahoma City OK
Assignee:
The Board of Regents of the University of Oklahoma - Norman OK
International Classification:
C12P 2106, C12N 910, C12N 120, C12N 500, C07H 2104
US Classification:
435 691
Abstract:
Tyrosylprotein sulfotransferases and nucleic acids encoding the tyrosylprotein sulfotransferases are described. Dual isotopes of the enzyme and of the nucleic acids encoding said enzymes have been identified in human, mouse and C. elegans. The polypeptides and polynucleotides exhibit a wide range of homologies. The polynucleotides can be used to transform or transfect host cells for producing substantially pure forms of the enzyme, or for use in an expression system for post-translational tyrosine sulfation of proteins or peptides produced within the expression system. The enzymes can be used to sulfate peptides or proteins requiring sulfation.
Glycoprotein Ligand For P-Selectin And Methods Of Use Thereof
US Patent:
5880091, Mar 9, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/473253
Inventors:
Richard D. Cummings - Edmond OK
Kevin L. Moore - Oklahoma City OK
Rodger P. McEver - Oklahoma City OK
Kevin L. Moore - Oklahoma City OK
Rodger P. McEver - Oklahoma City OK
Assignee:
The Board of Regents of the University of Oklahoma - Norman OK
International Classification:
A61K 3815, C07H 504
US Classification:
514 8
Abstract:
P-selectin has been demonstrated to bind primarily to a single major glycoprotein ligand on neutrophils and HL-60 cells, when assessed by blotting assays and by affinity chromatography of �. sup. 3 H!glucosamine-labeled HL-60 cell extracts on immobilized P-selectin. This molecule was characterized and distinguished from other well-characterized neutrophil membrane proteins with similar apparent molecular mass. The purified ligand, or fragments thereof (including both the carbohydrate and protein components), or antibodies to the ligand, or fragments thereof, can be used as inhibitors of binding of P-selectin to cells.
Tyrosylprotein Sulfotransferases And Methods Of Use Thereof
US Patent:
7316912, Jan 8, 2008
Filed:
Jan 20, 2006
Appl. No.:
11/336497
Inventors:
Kevin L. Moore - Oklahoma City OK, US
Assignee:
Siwa Biotech Corporation - Oklahoma City OK
International Classification:
C12Q 1/48, C12P 21/06
US Classification:
435 15, 435 691, 435 692, 435193, 536 232
Abstract:
Tyrosylprotein sulfotransferases and nucleic acids encoding the tyrosylprotein sulfotransferases are described. Dual isotopes of the enzyme and of the nucleic acids encoding said enzymes have been identified in human, mouse and. The polypeptides and polynucleotides exhibit a wide range of homologies. The polynucleotides can be used to transform or transfect host cells for producing substantially pure forms of the enzyme, or for use in an expression system for post-translational tyrosine sulfation of proteins or peptides produced within the expression system. The enzymes can be used to sulfate peptides or proteins requiring sulfation.